We are live on ! Find out more
TPTX

Turning Point Therapeutics, Inc. Common Stock
TPTX

Delisted

TPTX was delisted on the 16th of August, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Turning Point Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 208 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 208 → 0 (-208)

100% less funds holding in top 10

Funds holding in top 10: 10 → 0 (-10)

100% less capital invested

Capital invested by funds: $3.06B → $0 (-$3.06B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 208

Holders
–
Holders Change
-208
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
208
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$313M
2
BlackRock
BlackRock
New York
-$285M
3
CAM
Cormorant Asset Management
Massachusetts
-$187M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$144M
5
State Street
State Street
Massachusetts
-$124M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of New Jersey Common Pension Fund D
76
State of New Jersey Common Pension Fund D
New Jersey
– -$4.65M -61,832 Closed
PAMS
77
Pictet Asset Management (Switzerland)
Switzerland
– -$4.42M -58,673 Closed
California State Teachers Retirement System (CalSTRS)
78
California State Teachers Retirement System (CalSTRS)
California
– -$4.33M -57,586 Closed
CS
79
Credit Suisse
Switzerland
– -$4.18M -55,593 Closed
Citigroup
80
Citigroup
New York
– -$4.13M -54,839 Closed
Invesco
81
Invesco
Georgia
– -$4.12M -54,718 Closed
CC
82
Centiva Capital
New York
– -$3.76M -50,000 Closed
UBS AM
83
UBS AM
Illinois
– -$3.67M -48,759 Closed
DCM
84
DAFNA Capital Management
California
– -$3.65M -48,452 Closed
Bank of America
85
Bank of America
North Carolina
– -$3.56M -47,300 Closed
State of Wisconsin Investment Board
86
State of Wisconsin Investment Board
Wisconsin
– -$3.46M -45,955 Closed
Legal & General Group
87
Legal & General Group
United Kingdom
– -$3.08M -40,898 Closed
DAM
88
DLD Asset Management
New York
– -$3.01M -40,000 Closed
HS
89
HighVista Strategies
Massachusetts
– -$2.96M -39,384 Closed
Rafferty Asset Management
90
Rafferty Asset Management
New York
– -$2.95M -39,251 Closed
FAM
91
Fred Alger Management
New York
– -$2.84M -37,718 Closed
WAM
92
Wolverine Asset Management
Illinois
– -$2.73M -36,216 Closed
OR
93
Olympiad Research
Connecticut
– -$2.52M -33,427 Closed
New York State Common Retirement Fund
94
New York State Common Retirement Fund
New York
– -$2.49M -33,136 Closed
Tudor Investment Corp
95
Tudor Investment Corp
Connecticut
– -$2.42M -32,230 Closed
Susquehanna International Group
96
Susquehanna International Group
Pennsylvania
– -$2.35M -31,218 Closed
Fiera Capital (Canada)
97
Fiera Capital (Canada)
Quebec, Canada
– -$2.27M -30,235 Closed
HA
98
Havens Advisors
New York
– -$2.26M -30,000 Closed
Arrowstreet Capital
99
Arrowstreet Capital
Massachusetts
– -$2.12M -28,147 Closed
Ameriprise
100
Ameriprise
Minnesota
– -$2M -26,576 Closed
2 3
4
5 6

TPTX Hedge Fund Activity: Q3 2022 in Review

0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Turning Point Therapeutics, Inc. Common Stock (TPTX) for Q3 2022, worth a combined $0 — down 100% from $3.06B a quarter earlier.

Sellers outnumbered buyers: 208 funds closed out of TPTX and 0 opened new positions — a net loss of 208 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $313M sold.

  • 0 institutional investors held Turning Point Therapeutics, Inc. Common Stock (TPTX) as of Q3 2022, down from 208 in Q2 2022.
  • Funds reported $0 of Turning Point Therapeutics, Inc. Common Stock stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Turning Point Therapeutics, Inc. Common Stock positions in Q3 2022 and 208 closed out, a net change of -208 holders.
  • The largest Turning Point Therapeutics, Inc. Common Stock seller in Q3 2022 was Vanguard Group, an estimated $313M sold.

Based on aggregated 13F filings for Q3 2022.